Basel, Basel-Stadt, Switzerland EVA Basel appeared to be the Corporate Investor, which was created in 1996. The main department of described Corporate Investor is located in the Basel. The company was established in Europe in Switzerland.
The standard case for the fund is to invest in rounds with 2-3 partakers. Despite the EVA Basel, startups are often financed by Venture Kick, Zu00fcrcher Kantonal Bank, Neuromuscular Research Association Basel. The meaningful sponsors for the fund in investment in the same round are Zu00fcrcher Kantonal Bank, StartAngels Network, Redalpine Venture Partners. In the next rounds fund is usually obtained by Zu00fcrcher Kantonal Bank, SHS Gesellschaft fur Beteiligungsmanagement, Novo Seeds.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - Switzerland. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Robotics, Manufacturing. Among the various public portfolio startups of the fund, we may underline Memo Therapeutics, AOT - Advanced Osteotomy Tools, BioVersys AG The fund has exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.
Considering the real fund results, this Corporate Investor is 30 percentage points more often commits exit comparing to other organizations. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2015.
Related Funds
Funds with similar focus
| Fund Name | Location |
| 1to1 Venture Partners | Connecticut, Stamford, United States |
| Continuity Capital | Australia, Australian Capital Territory, Canberra |
| Elephant Capital | England, London, United Kingdom |
| Elscint Biomedical Investment | - |
| FreshDirect | Long Island City, New York, United States |
| Heritage Provider Network | California, Northridge, United States |
| Invictus Advisory Group | - |
| Kiwi II Venture Capital | - |
| Phyto Partners | Boca Raton, Florida, United States |
| Plutus Capital | New York, New York, United States |
| Real Tech Fund | Japan, Sumida |
| Solon | Arizona, Tucson, United States |
| Special Equities Group | - |
| Sports Industrial Fund of Zhejiang Province | - |
| The Contrarian Group | California, Newport Beach, United States |
| UGFS | Gabès, Tunis, Tunisia |
| University Hospitals | Cleveland, Ohio, United States |
| Wharton Capital | New York, New York, United States |
| Yangli Konggu | China, Liaoning, Shenyang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
POLYNEURON | $3M | 14 May 2018 | Basel, Basel-City, Switzerland | ||
POLYNEURON | $3M | 12 May 2016 | Basel, Basel-City, Switzerland | ||
Inthera Bioscience | $4M | 14 Dec 2015 | Zurich, Switzerland | ||
Memo Therapeutics | $2M | 22 Jul 2015 | Zurich, Zurich, Switzerland | ||
AOT - Advanced Osteotomy Tools | $1M | 25 Jan 2012 | Basel, Basel-City, Switzerland | ||
BioVersys | $2M | 31 Mar 2011 | Basel, Basel-City, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
POLYNEURON | $3M | 14 May 2018 | Basel, Basel-City, Switzerland | ||
POLYNEURON | $3M | 12 May 2016 | Basel, Basel-City, Switzerland | ||
Inthera Bioscience | $4M | 14 Dec 2015 | Zurich, Switzerland | ||
Memo Therapeutics | $2M | 22 Jul 2015 | Zurich, Zurich, Switzerland | ||
AOT - Advanced Osteotomy Tools | $1M | 25 Jan 2012 | Basel, Basel-City, Switzerland | ||
BioVersys | $2M | 31 Mar 2011 | Basel, Basel-City, Switzerland |
